< Back to previous page
Researcher
Steven De Vleeschouwer
- Disciplines:Biomechanics, Morphological sciences, Neurosciences, Biomarker discovery and evaluation, Drug discovery and development, Medicinal products, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences, Biological and physiological psychology, Cognitive science and intelligent systems, Developmental psychology and ageing
Affiliations
- Research Group Experimental Neurosurgery and Neuroanatomy (Division)
Responsible
From1 Jan 2013 → Today - Research Group Experimental Neurosurgery and Neuroanatomy (Division)
Member
From1 Aug 2001 → Today
Projects
1 - 10 of 22
- Molecular Brain Tumor DetectorFrom1 Feb 2024 → TodayFunding: Other EU initiatives out of framework
- The malignant Glioma immuno-oncology matchmaker: towards data-driven precision medicine using spatially resolved radio-multiomicsFrom1 Jan 2024 → TodayFunding: HORIZON.2.1 - Health
- Immunotherapy for childhood, adolescent, and adult Glioblastoma: towards tumour-immune interactions driven precision medicine using spatially resolved radio-multiomics.From15 Jan 2023 → TodayFunding: BOF - various
- Investigating the role of astrocytes and noradrenaline as critical regulators of neuronal circuit excitability.From1 Jan 2022 → TodayFunding: FWO research project (including WEAVE projects)
- De evidentie rond het coiling-clipping paradigma in de behandeling van cerebrale aneurysmata uitdagen en in kaart brengen door middel van multimodale stratificatie.From8 Dec 2021 → TodayFunding: FWO Strategic Basic Research Grant
- DIPITO: valorisation of deep immune profiling and novel immunotherapeutics for oncology.From1 Oct 2021 → TodayFunding: IOF - mandates
- Evaluating the Role of Autophagy in the Tumor Vasculature and as Anti-angiogenic Escape MechanismFrom1 Oct 2020 → 30 Sep 2021Funding: BOF - postdoctoral mandates
- Opening the brain blood barrier to treat brain tumoursFrom1 Jan 2020 → 31 Dec 2022Funding: H2020 - European Institute of Innovation and Technology, Horizon Europe - European Institute of Innovation and Technology (EIT)
- Screening of Hyp-PDT induced ICD-sensitive GBM Immunophenotype and Exploration of Synergetic Effect of Sonodynamic Therapy in GBM ImmunotherapyFrom2 Dec 2019 → 2 Dec 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Visual prostheses based on high resolution brain stimulationFrom1 Oct 2019 → 30 Sep 2023Funding: BOF - projects
Publications
81 - 90 of 141
- Biomarkers in de neuro-oncologie: ontwikkeling en validering als uitdaging voor de toekomstige behandelstrategieën(2015)
Authors: Steven De Vleeschouwer
Pages: 49 - 50 - Immune Suppression during Oncolotyic Virotherapy for High-Grade Glioma; Yes of No?(2015)
Authors: Steven De Vleeschouwer
Pages: 203 - 217 - Cerebraal abces met subduraal empyeem van dentale oorsprong: case report(2015)
Authors: J. Van Hevele, B. Veys, Joseph Schoenaers, Steven De Vleeschouwer, Constantinus Politis
Pages: 107 - 107 - Family Caregivers of Patients With a High-Grade Glioma: A Qualitative Study of Their Lived Experience and Needs Related to Professional Care(2015)
Authors: Annemarie Coolbrandt, Paul Clement, Marleen Decruyenaere, Steven De Vleeschouwer, Bernadette Dierckx de Casterlé
Pages: 406 - 143 - Re-irradiation or re-operation followed by dendritic cell(2015)
Authors: Steven De Vleeschouwer
Pages: 325 - 332 - Cerebraal abces met subduraal empyeem van dentale oorsprong: case report(2015)
Authors: J Van Hevele, B Veys, Joseph Schoenaers, Steven De Vleeschouwer, Constantinus Politis
Pages: 107 - 107 - The Basics of Cancer Immunity Dc-Based Immunotherapy: Gliomas as a Paradigm Disease?(2015)
Authors: Steven De Vleeschouwer, Jianxun Song
Pages: 69 - 90 - The Basics of Cancer Immunity Dc-Based Immunotherapy: Gliomas as a Paradigm Disease? - See more at: http://www.eurekaselect.com/130367/chapter/the-basics-of-cancer-immunity-dc-based-immunotherapy%3A-gliomas-as-a-paradigm-disease#sthash.lpVHeLE3.dpuf(2015)
Authors: Steven De Vleeschouwer
Pages: 69 - 90 - Re-irradiation or re-operation followed by dendritic cell(2015)
Authors: Steven De Vleeschouwer
Pages: 325 - 332 - Leven met een hersentumor: Impact op patiënt en mantelzorger, uitdagingen voor zorgverleners(2014)
Authors: Annemarie Coolbrandt, Paul Clement, Steven De Vleeschouwer
Pages: 8 - 12
Patents
1 - 3 of 3
- Treatment of central nervous tumours (Inventor)
- Treatment of central nervous tumours (Inventor)
- Treatment of central nervous tumours (Inventor)